Monopar Therapeutics
MNPR-101-Zr
multiple aggressive cancers
Date
TBD
Phase 1 readout · Date TBD estimated
What's at stake
Phase 1 trial results for MNPR-101-Zr in multiple aggressive cancers are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“Ongoing Phase 1 clinical activity in Australia for MNPR-101-Zr”